If Oxford’s Covid-19 Vaccine Succeeds, Layers of Private Investors Could Profit – The Wall Street Journal

In the race for a Covid-19 vaccine, the University of Oxford stands apart. The 900-year-old schools Jenner Institute is competing versus a variety of large, openly traded pharmaceutical business whose financiers could acquire handsomely from an effective jab.

Even at Oxford, though, layers of personal investors are poised behind the scenes to profit if the vaccine works. They consist of the university itself, two of the researchers at the center of the programs research and an obscure financial investment firm began in 2015 by a previous …